InsiderTrades

Form 4 for OGN Organon & Co.

Accepted 2025-02-24 00:00:00 ET · period of report 2025-02-20 · accession 0001859698-25-000004 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
M 2025-02-24 2025-02-20 OGN Ali Kevin CEO, Dir F - Tax $14.98 -55.1K 182.5K -23% -$825.3K
M 2025-02-24 2025-02-20 OGN Ali Kevin CEO, Dir A - Grant $0.00 +99.6K 229.1K +77% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-02-20 F D 8,529 $15.29 199,919.16 D — — (F3) Includes the addition of 10,490.157 shares of Common Stock acquired from dividend reinvestments not previously reported.
2 Common Common Stock 2025-02-20 A A 15,423 $0.00 197,958 D — — (F2) Represents the shares of Common Stock released to cover the dividend equivalents earned on the PSUs released above.
3 Common Common Stock 2025-02-20 F D 46,575 $14.92 182,535 D — —
4 Common Common Stock 2025-02-20 A A 84,222 $0.00 229,110 D — — (F1) Represents shares of Organon & Co. common stock ("Common Stock") for performance share units ("PSUs") granted to the reporting person on August 09, 2022 under the Organon & Co. 2021 Incentive Stock Plan. The performance-vesting restrictions with respect to these shares were released upon certification of performance goal attainment by the Talent Committee of Organon's Board of Directors.